The analysis revealed that biomarker suppression, and improved clinical outcomes achieved during two years of treatment with tezepelumab did not rebound but gradually waned after ...

Madrigal also expects to reinforce Rezdiffra’s clinical profile—and potentially convert the current accelerated approval to a ...

Early research suggests setanaxib combined with pembrolizumab may be a promising treatment for patients with squamous cell carcinoma of the head and neck.

Q2 2024 Earnings Call Transcript May 6, 2024 Enanta Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge ...

Calliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step one, show the molecule ...

Data on several novel injectable drugs were presented at the World Congress on Osteoarthritis, as well as updated data on the gene therapy XT-150.

(RTTNews) - NeuroSense Therapeutics (NRSN) announced new analyses from Phase 2b PARADIGM clinical trial, demonstrated a statistically significant slowing of disease progression in high-risk ALS ...

Key Takeaways An experimental anti-nicotine drug helps people quit vaping Vapers taking cytisinicline were twice as likely to quit as people taking a placebo The drug binds to nicotine receptors in ...

The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.

A supplement formulated with American ginseng, Brahmi, and coffee fruit extract could improve mood and working memory, ...

There’s a ton of classic New Wave, goth, and post-punk music on the bill. Here’s our greatest hits you should not miss.

Phase 2 ORCA-V1 trial showed treatment with cytisinicline more than doubled odds of quitting e-cigarettes compared with placebo Cytisinicline treatment well tolerated with no serious adverse events ...